Mustang Bio, Inc. (MBIO) vs Onconetix, Inc. (ONCO)
- Mustang Bio, Inc. MBIO 0.38 −2.56%
- Onconetix, Inc. ONCO 0.48 −12.73%
Mustang Bio, Inc. and Onconetix, Inc. are both Biotechnology companies. Mustang Bio, Inc. and Onconetix, Inc. are of similar size ($2.9M and $2.9M). Mustang Bio, Inc. has negative trailing earnings, so its P/E is not meaningful; Onconetix, Inc. trades at 0.0×. Mustang Bio, Inc. has the higher net margin (0.00% vs −1,578.6%) and the higher return on invested capital (0.00% vs −135.4%). Across the 13 metrics below, Mustang Bio, Inc. leads on 7 and Onconetix, Inc. on 6.
Valuation
Profitability
| Metric | MBIO | ONCO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 80.38% | 65.16% |
| Operating margin | 0.00% | (2,524.73%) | 0.00% |
| Net margin | 0.00% | (1,578.60%) | 0.00% |
| Free cash flow margin | 0.00% | (1,595.90%) | 0.00% |
| Return on equity | (58.12%) | (105.23%) | (56.36%) |
| Return on assets | (21.17%) | (57.37%) | (48.04%) |
| Return on invested capital | 0.00% | (135.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack